PEG-interferon versus conventional interferon and liver fibrosis: Do we have evidence of superiority? [4] (multiple letters)

Gastroenterology

Volumn 124, Issue 2, 2003, Pages 584-585

  Sander, Guilherme ^a   Picon, Paulo D ^a   Fuchs, Flávio D ^a   Beltrame, Alberto ^a   De Souza, Renilson R ^a   Poynard, Thierry ^b   McHutchison, John ^c   Manns, Michael ^d   Trepo, Christian ^e   Lindsay, Karen ^f   Goodman, Zachary ^f   Ling, Mei Shu ^f   Albrecht, Janice ^f  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e HÔTEL DIEU   (France)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

CHRONIC HEPATITIS; DATA ANALYSIS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; LETTER; LIVER FIBROSIS; PRIORITY JOURNAL;

EID: 0037309715     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50083     Document Type: Letter

References (0)